ZTrials

https://www.instagram.com/p/CIqL1QyDu1J/?igshid=1t2bzhnnt2si4

A New Research Study is now accepting patients. See link in bio. #endometriosis #research #study #sunset #painfulsex #painfulmenses #painfulperiods #womensupportingwomen #womenshealthmatters #women #womenempoweringwomen #womencoloradorunners #coloradolife #colorado

Updates to guidances:

ICH Official web site : ICH

https://www.empr.com/home/news/fda-approves-new-atypical-antipsychotic-caplyta-to-treat-schizophrenia-in-adults/

FDA Approves Caplyta for Schizophrenia - MPR The Food and Drug Administration (FDA) has approved Caplyta (lumateperone; Intra-Cellular Therapies), an atypical antipsychotic, for the treatment of schizophrenia in adult patients. The approval was based on results from 2 double-blind, placebo-controlled trials (Study 1 [N=335] and Study 2 [N=450]...

ORILISSA is a GnRH receptor antagonist.

ORILISSA® (elagolix) 150 mg or 200 mg Tablets | Official HCP Site The official ORILISSA® (elagolix) health care professional site from AbbVie Inc. Learn about the use, benefits, side effects, and risks of ORILISSA 150 mg or 200 mg tablets.

Take action! Reach out to your members of Congress.

Urge Your Members of Congress to Cosponsor PACT Act

Enter Your Information to Find Your Officials and Candidates, and Access a Voter Toolkit with Voter Registration Information and More!

bethematch.p2a.co Enter your information to learn who represents you!

Saving as many lives as possible is the mission. Learn more here:

Joy King - NMDP/Be The Match Mission This is "Joy King - NMDP/Be The Match Mission" by National Marrow Donor Program on Vimeo, the home for high quality videos and the people who love them.

Progress Report highlights the following:
1. Accomplishments of the BMT CTN, including a detailed report of the Network’s activities for the period of May 1, 2018, through April 30, 2019, (highlights bolded throughout the report) as well as plans for the upcoming year;
2. Organizational structure of the Network;
3. Structure, responsibilities, and focus of the Network’s Data and Coordinating Center (DCC);
4. Network collaborations;
5. Protocol selection, development, and management processes;
6. Past and current protocol status updates

web.emmes.com

OVAC’s united front enhances each organization’s ability to attain the funding levels necessary to win the war on cancer and to equip those facing cancer with the tools they need to fight this deadly disease.

One Voice Against Cancer (OVAC) One Voice Against Cancer (OVAC) is a collaboration of national non-profit organizations representing millions of Americans, delivering a unified message to Congress and the White House on the need for increased cancer-related appropriations.

FDA Approves Olaparib for gBRCAm Metastatic Pancreatic Adenocarcinoma

News & Analysis News & Analysis

DDIR scores could be used to guide treatment for triple negative breast cancer patients.

New Markers for Triple Negative Breast Cancer | SWOG Investigators from the SWOG Cancer Research Network, a cancer clinical trials network funded by the National Cancer Institute, part of the National Institutes of Health, confirm in research findings published in the Journal of Clinical Oncology that two biomarkers - a 44-gene DNA Damage Response (DD...